Rocket Pharmaceuticals (RCKT) PT Raised to $24 at Raymond James
Tweet
Share
E-mailGet Alerts RCKT Hot Sheet
Price: $3.47 +3.89%
Rating Summary:
15 Buy, 7 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
15 Buy, 7 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Raymond James analyst Timur Ivannikov raised the price target on Rocket Pharmaceuticals (NASDAQ: RCKT) to $24.00 (from $22.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Rocket Pharmaceuticals (RCKT) Tops Q2 EPS by 6c; offers guidance
- KP Tissue Inc. (KPT:CN) (KPTSF) PT Raised to Cdn$13.50 at Desjardins
- Calian Group Ltd (CGY:CN) (CLNFF) PT Raised to Cdn$109 at Desjardins
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
